Contraindicated (one)pentobarbital will lessen the extent or outcome of lorlatinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism.pentobarbital will reduce the level or effect of finasteride by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unknown.pentobarbital will reduce the extent or effect of cyclos